JP Patent

JP5822911B2 — 新規のｎｋ−３受容体選択的アンタゴニスト化合物、医薬組成物、及びｎｋ−３受容体媒介疾患における使用方法

Assigned to ユーロスクリーン エス．エー． · Expires 2015-11-25 · 10y expired

What this patent protects

Patent listed against Veozah.

Drugs covered by this patent

Patent Metadata

Patent number
JP5822911B2
Jurisdiction
JP
Classification
—
Expires
2015-11-25
Drug substance claim
No
Drug product claim
No
Assignee
ユーロスクリーン エス．エー．
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.